OTHER
About Us
We manufacture and stock quality-assured iPS cells and provide them at a reasonable price to academic research institutions and companies involved in the research and development of regenerative medicine using iPS cells.
News
RESEARCHES
CiRA Foundation and Terumo Joint Research Selected for AMED Funding
RESEARCHES
Provision of the New HLA Genome-edited iPS Cell Stock (Genome-edited line) for Clinical Use
RESEARCHES
One Genomics and CiRA Foundation Announce Strategic Research Collaboration to Advance Precision Genome Engineering
Our Services
iPS Cells
Our iPS cells are being used by more than 60 academic research institutions and companies for basic research and developing new therapies. More than 10 clinical trials have been conducted using our iPS cells.
Bridging Academia and Industry
We transfer iPS cell technology to companies and support their research and development.
Make a Gift
We greatly appreciate your support to further the application and commercialization of
iPS cells for regenerative medicine.
Discover more
